Frontiers in Pharmacology | Renal Pharmacology

Original Research

Published on 25 Jul 2023

Aspirin reduces the mortality risk of sepsis-associated acute kidney injury: an observational study using the MIMIC IV database

in Renal Pharmacology

Sining Chen
Shishi Li
Chaoying Kuang
Yuzhen Zhong
Zhiqian Yang
Yan Yang
Fanna Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1186384

14,700 views
10 citations

Systematic Review

Published on 24 Jul 2023

The efficacy and safety of cuttlebone for lowering serum phosphate in patients with end-stage renal disease: a meta-analysis of randomized controlled trials

in Renal Pharmacology

Hsiao-Tien Chen
Kuo-Chuan Hung
Chin-Wei Hsu
Jui-Yi Chen
Chien-Cheng Liu
I-Wen Chen
Cheuk-Kwan Sun

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1206366

3,204 views
1 citation

Original Research

Published on 21 Jul 2023

Effect of replacement therapy (CRRT) and hemodialysis (IHD) on severe acute renal failure

in Renal Pharmacology

Xiangyuan Zhang
Yinfang Yuan

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1122778

3,938 views
7 citations

Original Research

Published on 20 Jul 2023

Blockage of S100A8/A9 ameliorates septic nephropathy in mice

in Renal Pharmacology

Wei Shi
Tian-Tian Wan
Hui-Hua Li
Shu-Bin Guo

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1172356

4,877 views
11 citations

Original Research

Published on 07 Jul 2023

Rapamycin treatment induces tubular proteinuria: role of megalin-mediated protein reabsorption

in Renal Pharmacology

Rodrigo A. S. Peres
Diogo B. Peruchetti
Rodrigo P. Silva-Aguiar
Douglas E. Teixeira
Carlos P. Gomes
Christina M. Takiya
Ana Acacia S. Pinheiro
Celso Caruso-Neves

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1194816

5,747 views
4 citations

Review

Published on 26 Jun 2023

Treatment of obesity-related diabetes: significance of thermogenic adipose tissue and targetable receptors

in Renal Pharmacology

Ruping Pan
Jiadai Liu
Yong Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1144918

4,040 views
6 citations

Editorial

Published on 16 Jun 2023

Editorial: Be positive about the negative in pharmacology: clinical studies in renal pharmacology 2022

in Renal Pharmacology

Narayan Prasad
Brijesh Yadav

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1236750

2,449 views

Review

Published on 15 Jun 2023

Mitochondrial homeostasis: a potential target for delaying renal aging

in Renal Pharmacology

Ming Yang
Chongbin Liu
Na Jiang
Yan Liu
Shilu Luo
Chenrui Li
Hao Zhao
Yachun Han
Wei Chen
Li Li

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1191517

3,640 views
6 citations

Original Research

Published on 13 Jun 2023

The macrocyclic lactone oxacyclododecindione reduces fibrosis progression

in Renal Pharmacology

Sabrina Saurin
Myriam Meineck
Markus Rohr
Wilfried Roth
Till Opatz
Gerhard Erkel
Andrea Pautz
Julia Weinmann-Menke

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1200164

2,615 views
2 citations

Correction

Published on 09 Jun 2023

Corrigendum: Phyllanthus niruri L. exerts protective effects against the calcium oxalate-induced renal injury via ellgic acid

in Renal Pharmacology

Mao-Ting Li
Lu-Lu Liu
Qi Zhou
Lin-Xi Huang
Yu-Xuan Shi
Jie-Bin Hou
Hong-Tao Lu
Bing Yu
Wei Chen
Zhi-Yong Guo

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1207268

1,470 views

Original Research

Published on 08 Jun 2023

Molecular mechanism of Hedyotis Diffusae Herba in the treatment of lupus nephritis based on network pharmacology

in Renal Pharmacology

Jinfei Yang
Siying Li

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1118804

2,379 views
6 citations

Original Research

Published on 08 Jun 2023

The role of the SGK3/TOPK signaling pathway in the transition from acute kidney injury to chronic kidney disease

in Renal Pharmacology

Huapan Shu
Yumei Wang
Hui Zhang
Qingqing Dong
Lulu Sun
Yuchi Tu
Qianqian Liao
Li Feng
Lijun Yao

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1169054

6,809 views
4 citations

Opinion

Published on 06 Jun 2023

Dysfunction of von-Hippel Lindau factor causes reduced degradation of HIF leading to renal cancer. Hypoxia-inducible factor-prolyl hydroxylase enzyme inhibitors also lessen HIF destruction and could therefore increase renal cancer

in Renal Pharmacology

Helge Waldum

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1170796

1,608 views
3 citations

General Commentary

Published on 30 May 2023

Commentary: Protective effect of quercetin on kidney diseases: from chemistry to herbal medicines

in Renal Pharmacology

Weiya Kong
Yage Zhang
Liangchen Luo
Qiaoyin Tan

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1214664

2,714 views

Original Research

Published on 25 May 2023

APOC1 exacerbates renal fibrosis through the activation of the NF-κB signaling pathway in IgAN

in Renal Pharmacology

Kuipeng Yu
Lin Ding
Xin An
Yanjiang Yang
Xiaoning Zhang
Luyao Li
Chunjie Wang
Fang Bai
Xiangdong Yang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1181435

6,331 views
8 citations

Systematic Review

Published on 24 May 2023

Safety of HIF prolyl hydroxylase inhibitors for anemia in dialysis patients: a systematic review and network meta-analysis

in Renal Pharmacology

Dinghua Chen
Yue Niu
Fei Liu
Yue Yang
Xue Wang
Ping Li
Xiangmei Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1163908

8,092 views
12 citations